Anthracycline-based breast cancer chemotherapy linked to neurotoxicity

[News]

Breast cancer patients treated with anthracycline-based chemotherapy regimens may be at greater risk of neurocognitive problems than those given nonanthracycline regimens, indicate findings.

More... (http://www.news-medical.net/news/20151204/Anthracycline-based-breast-cancer-chemotherapy-linked-to-neurotoxicity.aspx)